Xuefeng Li

6.3k total citations · 1 hit paper
139 papers, 3.8k citations indexed

About

Xuefeng Li is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xuefeng Li has authored 139 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 29 papers in Cancer Research and 25 papers in Immunology. Recurrent topics in Xuefeng Li's work include MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (16 papers) and Immune Cell Function and Interaction (10 papers). Xuefeng Li is often cited by papers focused on MicroRNA in disease regulation (19 papers), Cancer-related molecular mechanisms research (16 papers) and Immune Cell Function and Interaction (10 papers). Xuefeng Li collaborates with scholars based in China, United States and Australia. Xuefeng Li's co-authors include Dong‐Ming Kuang, Limin Zheng, Yan Wu, Qiyi Zhao, Min Wu, Xiang‐Ming Lao, Xikun Zhou, Christos Xiao, Minmin Chen and Fang‐Zhu Ouyang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Xuefeng Li

132 papers receiving 3.8k citations

Hit Papers

Cancer immunotherapy based on image-guided STING activati... 2022 2026 2023 2024 2022 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles
    2022 151 citations Xuefeng Li, Yifan Wang et al. Nature Nanotechnology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefeng Li China 33 1.5k 1.1k 812 757 548 139 3.8k
Hamed Mohammadi Iran 35 1.3k 0.9× 1.4k 1.2× 569 0.7× 733 1.0× 356 0.6× 130 3.9k
Lu Li China 42 2.3k 1.6× 1.2k 1.1× 496 0.6× 547 0.7× 552 1.0× 329 6.1k
Xiaoli Feng China 34 1.2k 0.8× 605 0.5× 521 0.6× 767 1.0× 386 0.7× 155 3.4k
Jarosław Baran Poland 27 1.9k 1.3× 1.2k 1.1× 925 1.1× 467 0.6× 463 0.8× 110 4.0k
Hua Tang China 34 2.4k 1.6× 1.6k 1.4× 890 1.1× 431 0.6× 378 0.7× 137 4.7k
Leili Aghebati‐Maleki Iran 47 2.4k 1.7× 1.9k 1.7× 641 0.8× 954 1.3× 642 1.2× 219 6.4k
Majid Ahmadi Iran 40 1.3k 0.9× 1.3k 1.1× 479 0.6× 454 0.6× 359 0.7× 103 4.2k
Quan Liu China 29 1.7k 1.2× 1.3k 1.2× 696 0.9× 425 0.6× 780 1.4× 85 4.2k
Qing Zhang China 35 2.0k 1.4× 1.3k 1.2× 636 0.8× 1.2k 1.6× 295 0.5× 184 4.9k
Honglin Wang China 33 1.3k 0.9× 1.8k 1.6× 548 0.7× 452 0.6× 255 0.5× 165 4.6k

Countries citing papers authored by Xuefeng Li

Since Specialization
Citations

This map shows the geographic impact of Xuefeng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefeng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefeng Li more than expected).

Fields of papers citing papers by Xuefeng Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefeng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefeng Li. The network helps show where Xuefeng Li may publish in the future.

Co-authorship network of co-authors of Xuefeng Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefeng Li. A scholar is included among the top collaborators of Xuefeng Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefeng Li. Xuefeng Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Huaxuan, et al.. (2024). SERPINE1AS2 regulates intramuscular adipogenesis by inhibiting PAI1 protein expression. International Journal of Biological Macromolecules. 275(Pt 2). 133592–133592. 2 indexed citations
2.
Huang, Yee, et al.. (2024). Characterization and immunological effect of outer membrane vesicles from Pasteurella multocida on macrophages. Applied Microbiology and Biotechnology. 108(1). 238–238. 3 indexed citations
3.
Wang, Zhuyuan, Ting Hu, Mike Tebyetekerwa, et al.. (2024). Electricity generation from carbon dioxide adsorption by spatially nanoconfined ion separation. Nature Communications. 15(1). 2672–2672. 12 indexed citations
4.
Li, Xuefeng, et al.. (2024). Causal Relationship Between Autoimmune Arthritis and Temporomandibular Disorders. International Dental Journal. 75(2). 596–604.
5.
6.
Li, Xuefeng, Kristin Huntoon, Yifan Wang, et al.. (2023). Radiation Synergizes with IL2/IL15 Stimulation to Enhance Innate Immune Activation and Antitumor Immunity. Molecular Cancer Therapeutics. 23(3). 330–342. 2 indexed citations
7.
Li, Junxing, Xuemei Cui, Xuefeng Li, et al.. (2023). Isolation, Identification and Drug Resistance Rates of Bacteria from Pigs in Zhejiang and Surrounding Areas during 2019–2021. Veterinary Sciences. 10(8). 502–502. 6 indexed citations
8.
9.
Li, Xuefeng, Yifan Wang, Kristin Huntoon, et al.. (2022). Cancer immunotherapy based on image-guided STING activation by nucleotide nanocomplex-decorated ultrasound microbubbles. Nature Nanotechnology. 17(8). 891–899. 151 indexed citations breakdown →
10.
Lü, Yifei, Kristin Huntoon, DaeYong Lee, et al.. (2022). Immunological conversion of solid tumours using a bispecific nanobioconjugate for cancer immunotherapy. Nature Nanotechnology. 17(12). 1332–1341. 48 indexed citations
11.
Li, Xuefeng, et al.. (2022). Comparison the effects of finerenone and SGLT2i on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus: A network meta-analysis. Frontiers in Endocrinology. 13. 1078686–1078686. 6 indexed citations
12.
Zhang, Yu, Yan Zhang, Qiong Chen, et al.. (2021). Factors Associated with Gestational Diabetes Mellitus: A Meta-Analysis. Journal of Diabetes Research. 2021. 1–18. 55 indexed citations
13.
Li, Ling, Ming Yang, Xuefeng Li, & Fu Liu. (2020). Efficacy and safety of lifitegrast in the treatment of dry eye disease: a Meta-analysis. SHILAP Revista de lepidopterología. 1 indexed citations
14.
Gong, Ping, Yifan Wang, Pengfei Zhang, et al.. (2020). Immunocyte Membrane-Coated Nanoparticles for Cancer Immunotherapy. Cancers. 13(1). 77–77. 75 indexed citations
15.
Liu, Guangyan, Min Xie, Ming Zhao, et al.. (2019). IGF-1R Inhibition Suppresses Cell Proliferation and Increases Radiosensitivity in Nasopharyngeal Carcinoma Cells. Mediators of Inflammation. 2019. 1–9. 20 indexed citations
16.
Li, Rongpeng, Lizhu Fang, Qinqin Pu, et al.. (2018). MEG3-4 is a miRNA decoy that regulates IL-1β abundance to initiate and then limit inflammation to prevent sepsis during lung infection. Science Signaling. 11(536). 79 indexed citations
17.
Zhou, Xikun, Xuefeng Li, & Min Wu. (2018). miRNAs reshape immunity and inflammatory responses in bacterial infection. Signal Transduction and Targeted Therapy. 3(1). 14–14. 121 indexed citations
18.
Xiao, Christos, Xiang‐Ming Lao, Minmin Chen, et al.. (2016). PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression. Cancer Discovery. 6(5). 546–559. 268 indexed citations
19.
Kuang, Dong‐Ming, Christos Xiao, Qiyi Zhao, et al.. (2014). B7-H1–expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets. Journal of Clinical Investigation. 124(10). 4657–4667. 68 indexed citations
20.
Li, Xuefeng. (2012). Research progress in bladder cancer markers and its detection methods. 24(5). 351–354. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hamed Mohammadi Breakdown of academic impact, for papers by Lu Li Breakdown of academic impact, for papers by Xiaoli Feng Breakdown of academic impact, for papers by Jarosław Baran Breakdown of academic impact, for papers by Hua Tang Breakdown of academic impact, for papers by Leili Aghebati‐Maleki Breakdown of academic impact, for papers by Majid Ahmadi Breakdown of academic impact, for papers by Quan Liu Breakdown of academic impact, for papers by Qing Zhang Breakdown of academic impact, for papers by Honglin Wang
Rankless by CCL
2026